These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15632207)

  • 1. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
    Keller MA; Martinez J; Baradet TC; Nagaswami C; Chernysh IN; Borowski MK; Surrey S; Weisel JW
    Blood; 2005 Apr; 105(8):3162-8. PubMed ID: 15632207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.
    Martinez J; Holburn RR; Shapiro SS; Erslev AJ
    J Clin Invest; 1974 Feb; 53(2):600-11. PubMed ID: 11344575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel mutations in the fibrinogen γ nodule.
    Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
    Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
    Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
    Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
    Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
    Mullin JL; Gorkun OV; Lord ST
    Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
    Amri Y; Jouini H; Becheur M; Dabboubi R; Mahjoub B; Messaoud T; Sfar MT; Casini A; de Moerloose P; Toumi NEH
    Haemophilia; 2017 Jul; 23(4):e340-e347. PubMed ID: 28594476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
    Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
    Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
    Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
    Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel fibrinogen variant (fibrinogen Seoul II; AalphaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking.
    Park R; Doh HJ; An SS; Choi JR; Chung KH; Song KS
    Blood; 2006 Sep; 108(6):1919-24. PubMed ID: 16735602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional study of abnormal fibrinogen caused by Arg275His mutation in fibrinogen γ chain].
    Zhou JY; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):190-4. PubMed ID: 23683413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Lima. A new dysfibrinogenaemia with a high-molecular-weight alpha-chain and effective polymerization.
    Arocha-Piñango CL; Rodriguez S; Nagy H; Perez Requejo JL
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):561-5. PubMed ID: 2133234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis.
    Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
    Koopman J; Haverkate F; Briët E; Lord ST
    J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.
    Zhu L; Zhao M; Wang M; Lou Z; Chen X; Pan L; Yu D; Xia W; Wang H; Zhou B; Gao S
    J Thromb Thrombolysis; 2018 Aug; 46(2):211-218. PubMed ID: 29748775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.